Related MeSH Hierarchy (5)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms » Intestinal Neoplasms » Colorectal Neoplasms » Rectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms » Intestinal Neoplasms » Colorectal Neoplasms » Rectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms » Intestinal Neoplasms » Colorectal Neoplasms » Rectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Intestinal Neoplasms » Colorectal Neoplasms » Rectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Rectal Diseases » Colorectal Neoplasms » Rectal Neoplasms
Hierarchy View
Subtype Terms (1)
Anus Neoplasms
52 drugs (32 approved, 20 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (23)
Phase 3 Indicated Drugs (25)
Phase 2 Indicated Drugs (70)
Phase 1 Indicated Drugs (34)
Other Experimental Indicated Drugs (16)
Organization Involved with Phase 4 Indications (18)
Organization Involved with Phase 3 Indications (104)
Assistance Publique - Hôpitaux de Paris
Austrian Breast and Colorectal Cancer Group
Blokhin's Russian Cancer Research Center
Cancer and Leukemia Group B (CALGB)
Catholic University of Sacred Heart, Rome
Centre des Hautes Energie, Toulouse
Chinese Academy of Medical Sciences
CSSS Champlain - Charles-Lemoyne Hospital
Eastern Cooperative Oncology Group
European Organisation for Research and Treatment of Cancer
Federation Francophone de Cancerologie Digestive
German Rectal Cancer Study Group
IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest
Institut de Cancérologie de Lorraine
Institut de Cancerologie de l'Ouest Paul Papin
Jilin Provincial Tumor Hospital
National Cancer Institute (NCI)
North Central Cancer Treatment Group
Radiation Therapy Oncology Group
Organization Involved with Phase 2 Indications (213)
Academic and Community Cancer Research United
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials
Badalona Hospital Germans Trias i Pujol
Biocompatibles International plc
British Columbia Cancer Agency
Cancer Hospital of Yunnan provinceal
Chao Family Comprehensive Cancer Center
Chengdu Third People's Hospital
Chinese University of Hong Kong
City of Hope National Medical Center
Clinical Research Support Center Kyush
Clinica Universidad de Navarra
Generic Devices Consulting, Inc.
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Grupo Espanol Multidisciplinario del Cancer Digestivo
Gruppo Oncologico del Nord-Ovest
Holy Name Medical Center, Teaneck, NJ
Hoosier Cancer Research Network
Hospital General Universitario de Castellón
Hospital Universitario Arnau de Vilanova de Lleida
Hospital Universitario Madrid Sanchinarro
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Istituto Nazionale per lo Studio e la Cura dei Tumori
Japan Clinical Cancer Research Organization
John Muir Physician Network Clinical Research Center
King Faisal Specialist Hospital
Loma Linda Oncology Medical Group, Inc.
Memorial Sloan-Kettering Cancer Center
Methodist Cancer Center, Houston, Texas
National Cancer Center Hospital East
National Cheng Kung University
National Comprehensive Cancer Network
National Institutes of Health (NIH)
Oregon Health and Science University
Ottawa Regional Cancer Foundation
Phoenix Clinical Research Center
Polo Oncologico Area Vasta Nord Ovest
Radiological Society of North America
Saiseikai Fukuoka General Hospital
Shahid Beheshti University of Medical Sciences
Shanghai Minimally Invasive Surgery Center
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
State University of New York, Buffalo
St. Luke's-Roosevelt Hospital Center
Swiss Group for Clinical Cancer Research
Taichung Veterans General Hospital
Taipei Veteran General hospital
The First People's Hospital of Changzhou
The University of Texas, Dallas
Trans Tasman Radiation Oncology Group
Universidad Autonoma de Barcelona
Universidad Autonoma de Madrid
Universidad Complutense de Madrid
University of British Columbia
University of California, Irvine
University of California, San Diego
University of California, San Francisco
University of Colorado, Denver
University of Electronic Science and Technology of China
University of Medicine and Dentistry of New Jersey
University of North Carolina at Chapel Hill
University of Southern California
University of Texas, San Antonio
Organization Involved with Phase 1 Indications (18)
Organization Involved with Other Experimental Indications (16)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
